Without biochemistry (n=10,727) With biochemistry (n=1,072)
Insulin 1.471 (1.195-1.811) 1.564 (0.855-2.861)
Biguanide 0.395 (0.321-0.487) 0.395 (0.215-0.724)
β-cell stimulating 0.968 (0.781-1.200) 0.865 (0.462-1.619)
Glitazones 0.391 (0.096-1.585) -*
DPP-4 inhibitors 0.502 (0.325-0.775) 0.636 (0.194-2.090)
GLP-1: Liraglutide 0.217 (0.127-0.372) -*
GLP-1: Exenatide 0.699 (0.370-1.320) 1.571 (0.203-12.165)
Hypertension 1.578 (1.140-2.185) 2.031 (0.620-6.651)
Statins 0.856 (0.673-1.090) 1.025 (0.449-2.339)
Table 3: Crude odds ratios (95 % CI) for the AMI outcome in DM patients Selected variables of pharmaceutical use are presented, n = number, bold indicates significance *Predicts failure perfectly and not included in the analysis